1. Home
  2. AVX vs LTRN Comparison

AVX vs LTRN Comparison

Compare AVX & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AVX

Avax One Technology Ltd.

N/A

Current Price

$5.37

Market Cap

47.2M

Sector

Industrials

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$3.60

Market Cap

46.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVX
LTRN
Founded
2017
2013
Country
Canada
United States
Employees
7
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
46.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AVX
LTRN
Price
$5.37
$3.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
108.1K
183.8K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$1.11
52 Week High
$6.40
$5.74

Technical Indicators

Market Signals
Indicator
AVX
LTRN
Relative Strength Index (RSI) 67.32 50.22
Support Level $4.80 $3.09
Resistance Level $6.32 $3.79
Average True Range (ATR) 0.57 0.35
MACD -0.16 -0.10
Stochastic Oscillator 38.24 46.51

Price Performance

Historical Comparison
AVX
LTRN

About AVX Avax One Technology Ltd.

AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure. The Company builds modular data centers in regions with access to energy resources, using behind-the-meter generation and microgrid design to provide compute capacity for AI and high-performance computing (HPC) workloads. In addition, the company mines Bitcoin in Alberta and Ohio, operating at a hashrate of approximately 300 PH/s. The Company also maintains an Avalanche digital asset treasury, accumulating AVAX and generating onchain yield through native staking and ecosystem participation.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: